Showing 921-930 of 9129 results for "".
Are We Overlooking Skin Cancer in Ethnic Minorities?
https://practicaldermatology.com/issues/supplements/are-we-overlooking-skin-cancer-in-ethnic-minorities/21718/Skin cancers in Hispanic and African American patients may be detected at more advanced stages, leading to poorer prognoses and long-term outcomes compared to non-Hispanic whites.How to Integrate Physician-Dispensed Products
https://practicaldermatology.com/topics/general-topics/PD0609_10-php/22819/With the correct protocols, staff training, and product selection, physician dispensing can help retain your current patient base and assist in marketing to new patients.Clinical Conversations Video with Dr Scott Boswell
https://practicaldermatology.com/programs/nemluvio-peer-network/clinical-conversations-video-with-dr-scott-boswell/56420/Join Dr Scott Boswell as he shares how he approaches prurigo nodularis (PN) and atopic dermatitis (AD) in his expansive dermatology practice. From his 3‑step communication framework to compelling patient stories, Dr Boswell emphasizes how prioritizing safety and understanding neuroimmune mechanismsBridging the Gap Between Hair Care and Skincare
https://practicaldermatology.com/topics/hair-nails/bridging-the-gap-between-hair-care-and-skincare/23800/Hair care can have an impact on scalp, face, and body skin, which demonstrates the need to consider hair care products’ intersection with the skincare category.GLP-1 Receptor Agonists and the Aesthetic Patient: Considerations for the Dermatologist
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-and-the-aesthetic-patient/48900/The impact of glucagon-like peptide-1 agonists (GLP-1), such as semaglutide, tirzepatide and liraglutide, has transformed the healthcare industry and, in particular, aesthetic dermatology. The most common intended use of these medications, namely diabetes management and weight loss, can lead to a muTargeting the OX40 Pathway
https://practicaldermatology.com/issues/october-2025/targeting-the-ox40-pathway/39764/A Promising New Avenue in Atopic DermatitisVitiligo: Understanding Your Options
https://practicaldermatology.com/youngmd-connect/wrap-ups/vitiligo-understanding-your-options/29890/Showing up is half the battle, it has often been said. According to dermatologist Nanette Silverberg, MD, FAAP, FAAD, chief of pediatric dermatology at Mount Sinai Health System in New York, that adage applied to the attendees at a recent YoungMD Connect virtual session featuring two expert presentaIn The Pipeline: Phase 1, 2, and 3
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/pipeline-phase-1-2-and-3/29087/This summary provides the latest news on of some of the recent Phase 1, Phase 2, and Phase 3 clinical studies for psoriasis treatments.The Landscape for Vitiligo: An Interview with Larry Green, MD
https://practicaldermatology.com/topics/pigmentary-disorders/the-landscape-for-vitiligo-an-interview-with-larry-green-md/24209/Practical Dermatology® Chief Medical Editor Neal Bhatia, MD, FAAD, talked with Larry Green, MD, a board-certified dermatologist in private practice in Rockville, Maryland, about the latest in vitiligo treatment and what practitioners can tell their patients about recent advances in treatment for thiThe Digital Dermatologist: Why Physicians Should Embrace Coding Skills in the Modern Era
https://practicaldermatology.com/programs/practical-dermatology/the-digital-dermatologist-why-physicians-should-embrace-coding-skills-in-the-modern-era/24034/A changing digital landscape means practitioners need to keep their digital toolkits up to date.